Brief introduction and detailed information of Beijing Wan Tai Biopharmaceutical Co., Ltd.

As a national biological high-tech industrialization demonstration project base, Development has passed the quality system certification such as GMP/ISO13485/ISO 9001,undertaken many scientific research projects such as the National 863 Plan, the Ninth Five-Year Plan, the Ministry of Education and provincial (municipal) key research projects, and devoted itself to the rapid transformation of research results of scientific research institutions to realize their industrialization. On June 5438+ 10, 2006, the company moved into the new site of Zhongguancun Life Science Park, covering an area of 52 mu, with a production plant area of more than 20,000 square meters, and passed the GMP certification of the US Food and Drug Administration in August of the same year. Since it passed the national GMP certification for the first time in 2000, the company has accumulated more than 8 years of experience in GMP operation and management. Million-level clean production environment and perfect quality management system provide reliable guarantee for the excellent quality and stability of products. At the end of 2007, the company completed the shareholding system reform and officially changed into a joint stock limited company, which laid a solid financial foundation for the company's future large-scale and diversified development.

Wan Tai has the largest world-class production and manufacturing base of diagnostic reagents and genetically engineered vaccines in China. The company mainly produces AIDS virus (HIV) diagnostic reagents, hepatitis B virus (HBV) complete diagnostic reagents, hepatitis C virus (HCV) diagnostic reagents, hepatitis E virus (HEV) diagnostic reagents, syphilis diagnostic reagents (TP, TRUST), rotavirus (RV) diagnostic reagents, T-lymphocyte leukemia virus antibody (HTLV) and other blood station and hospital rapid diagnostic reagents. The company provides a complete set of reagents for blood source screening: HBsAg, HCV, HIV, TP and TRUST. The products have advanced technology and stable quality, and the batches have passed the verification of China Institute for the Control of Pharmaceutical and Biological Products. The company pursues the business philosophy of "quality first, service to users", and is determined to become an advanced clinical medical biological diagnostic reagent enterprise in China with high-quality products, good company reputation and excellent after-sales service.

Through years of practical exploration and theoretical combination, Wan Tai Company has established a multi-level and three-dimensional sales team and sales network, with more than 30 provincial general agents and more than 300 regional agents at prefecture and city levels. Wan Tai's products have been exported to more than 30 countries and regions such as the Philippines, Iran, Indonesia, India, Brazil and South Africa, and have been widely praised by foreign customers. Excellent products and successful marketing strategies keep the market share of the company's products in a leading position in China. From 197 to 10 in 2008, the company's sales maintained a sustained and rapid growth, from less than 2 million yuan to1500 thousand yuan in 2008, an increase of 88 times.

It is the far-sighted strategic policy of Wan Tai Company to push high-quality products to the international market, introduce international leading technology, serve the China market and realize leap-forward development. Wan Tai Company keeps close contact with international organizations such as the World Health Organization (WHO) and International Blood Transfusion Safety Association (ICBS), and has established good cooperative relations with world-renowned enterprises such as BIO-RAD Company of the United States and OMEGA Company of the United Kingdom. We have reason to believe that China's biotechnology industry will rapidly grow into a giant commensurate with its international status with the efforts of many China biotechnology enterprises, including Wan Tai Company!